NO20044700L - Ny assoiasjon av et antitrombotisk middel og aspirin - Google Patents
Ny assoiasjon av et antitrombotisk middel og aspirinInfo
- Publication number
- NO20044700L NO20044700L NO20044700A NO20044700A NO20044700L NO 20044700 L NO20044700 L NO 20044700L NO 20044700 A NO20044700 A NO 20044700A NO 20044700 A NO20044700 A NO 20044700A NO 20044700 L NO20044700 L NO 20044700L
- Authority
- NO
- Norway
- Prior art keywords
- aspirin
- antithrombotic agent
- new association
- association
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Den foreliggende oppfinnelse vedrører en ny assosiasjon av et antitrombotisk middel og aspirin og farmasøytiske sammensetninger omfattende dem.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0204222A FR2838057B1 (fr) | 2002-04-05 | 2002-04-05 | Nouvelle association d'un antithrombotique et d'aspirine |
PCT/FR2003/001054 WO2003084525A1 (fr) | 2002-04-05 | 2003-04-04 | Nouvelle association d'un antithrombotique et d'aspirine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044700L true NO20044700L (no) | 2004-10-29 |
Family
ID=28052120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044700A NO20044700L (no) | 2002-04-05 | 2004-10-29 | Ny assoiasjon av et antitrombotisk middel og aspirin |
Country Status (27)
Country | Link |
---|---|
US (1) | US7618955B2 (no) |
EP (1) | EP1496884B1 (no) |
JP (1) | JP4065853B2 (no) |
KR (1) | KR100645143B1 (no) |
CN (1) | CN1297265C (no) |
AR (1) | AR039253A1 (no) |
AT (1) | ATE329591T1 (no) |
AU (1) | AU2003246774B2 (no) |
BR (1) | BR0309019A (no) |
CA (1) | CA2480697A1 (no) |
CY (1) | CY1105106T1 (no) |
DE (1) | DE60306133T2 (no) |
DK (1) | DK1496884T3 (no) |
EA (1) | EA006978B1 (no) |
ES (1) | ES2264533T3 (no) |
FR (1) | FR2838057B1 (no) |
GE (1) | GEP20074101B (no) |
HK (1) | HK1076034A1 (no) |
MA (1) | MA27114A1 (no) |
MX (1) | MXPA04009760A (no) |
NO (1) | NO20044700L (no) |
NZ (1) | NZ535430A (no) |
PL (1) | PL371620A1 (no) |
PT (1) | PT1496884E (no) |
UA (1) | UA79457C2 (no) |
WO (1) | WO2003084525A1 (no) |
ZA (1) | ZA200407593B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4880685B2 (ja) * | 2005-07-22 | 2012-02-22 | ザ プロクター アンド ギャンブル カンパニー | 薬物による不整脈の発生を低減するための組成物 |
EP2591783A1 (en) * | 2007-04-13 | 2013-05-15 | Millennium Pharmaceuticals, Inc. | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
JP2009001537A (ja) * | 2007-06-25 | 2009-01-08 | Lab Servier | 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用 |
FR2920772B1 (fr) * | 2007-09-11 | 2009-10-23 | Servier Lab | Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2711139B1 (fr) * | 1993-10-15 | 1995-12-01 | Adir | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
2002
- 2002-04-05 FR FR0204222A patent/FR2838057B1/fr not_active Expired - Fee Related
-
2003
- 2003-04-04 KR KR1020047015845A patent/KR100645143B1/ko not_active IP Right Cessation
- 2003-04-04 ES ES03745819T patent/ES2264533T3/es not_active Expired - Lifetime
- 2003-04-04 BR BR0309019-1A patent/BR0309019A/pt not_active IP Right Cessation
- 2003-04-04 AT AT03745819T patent/ATE329591T1/de not_active IP Right Cessation
- 2003-04-04 PL PL03371620A patent/PL371620A1/xx not_active Application Discontinuation
- 2003-04-04 DE DE60306133T patent/DE60306133T2/de not_active Expired - Fee Related
- 2003-04-04 CN CNB038078619A patent/CN1297265C/zh not_active Expired - Fee Related
- 2003-04-04 DK DK03745819T patent/DK1496884T3/da active
- 2003-04-04 AR ARP030101180A patent/AR039253A1/es unknown
- 2003-04-04 AU AU2003246774A patent/AU2003246774B2/en not_active Ceased
- 2003-04-04 NZ NZ535430A patent/NZ535430A/en unknown
- 2003-04-04 CA CA002480697A patent/CA2480697A1/fr not_active Abandoned
- 2003-04-04 WO PCT/FR2003/001054 patent/WO2003084525A1/fr active IP Right Grant
- 2003-04-04 EA EA200401293A patent/EA006978B1/ru not_active IP Right Cessation
- 2003-04-04 EP EP03745819A patent/EP1496884B1/fr not_active Expired - Lifetime
- 2003-04-04 US US10/509,605 patent/US7618955B2/en not_active Expired - Fee Related
- 2003-04-04 PT PT03745819T patent/PT1496884E/pt unknown
- 2003-04-04 JP JP2003581765A patent/JP4065853B2/ja not_active Expired - Fee Related
- 2003-04-04 GE GEAP8486A patent/GEP20074101B/en unknown
- 2003-04-04 UA UA20041109009A patent/UA79457C2/uk unknown
- 2003-04-04 MX MXPA04009760A patent/MXPA04009760A/es active IP Right Grant
-
2004
- 2004-09-21 ZA ZA200407593A patent/ZA200407593B/xx unknown
- 2004-10-29 NO NO20044700A patent/NO20044700L/no not_active Application Discontinuation
- 2004-11-03 MA MA27925A patent/MA27114A1/fr unknown
-
2005
- 2005-09-16 HK HK05108135A patent/HK1076034A1/xx not_active IP Right Cessation
-
2006
- 2006-07-24 CY CY20061101027T patent/CY1105106T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60225040D1 (de) | Montelukast-granulatformulierung | |
NO962187D0 (no) | Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav | |
DK1198233T3 (da) | Sulfonamid- og sulfamidsubstituerede imidazoquinoliner | |
IS8051A (is) | Kladríbínefnablöndur til inngjafar um munn | |
TNSN04206A1 (en) | Novel perindopril salt and pharmaceutical compositions containing same | |
DK0994710T4 (da) | Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
DE69840603D1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
ATE445389T1 (de) | Liposomale glucocorticoide | |
ATE409065T1 (de) | Inhibitoren der 17 beta- hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
HUP0400850A2 (hu) | Orálisan adagolható gyógyászati készítmények | |
HUP0301991A2 (hu) | IL-18-inhibitorok alkalmazása atheroszklerózis kezelésére és/vagy megelżzésére | |
ATE282607T1 (de) | Tryptase-inhibitoren | |
ATE454385T1 (de) | Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung | |
DK1404304T3 (da) | Tablet omfattende cetirizin og pseudoephedrin | |
HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
BR0314129A (pt) | Formulações de liberação modificadas de oxcarbazepina e derivados destas | |
NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
CR7198A (es) | Tableta que contiene cetirizina y pseudoefedrina | |
DK1355906T3 (da) | 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem | |
NO20065903L (no) | Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den | |
NO20044700L (no) | Ny assoiasjon av et antitrombotisk middel og aspirin | |
HUP0202638A2 (hu) | Fermentált búzacsíra-kivonat alkalmazása gyulladáscsökkentő készítmények előállítására | |
HUP0401633A2 (hu) | Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |